Cannabis and Endometriosis Pain
Patient surveys suggest symptom relief, but no clinical trials exist yet.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
About 10–25% of people with endometriosis report trying cannabis, mostly for pain and sleep—and most say it helps. But those are self-reports, not controlled studies. We have no human trials proving cannabis works in endometriosis, no evidence it shrinks lesions, and no way to know the right dose, type, or route. It might be useful as a supplementary tool, but it's not a replacement for surgery, hormones, or NSAIDs.
Plain-language summary
Endometriosis is a chronic inflammatory condition in which tissue similar to the uterine lining grows outside the uterus, causing pelvic pain, painful periods, painful sex, bowel and bladder symptoms, fatigue, and sometimes infertility. It affects roughly 10% of people assigned female at birth of reproductive age [1] Strong evidence.
Standard treatments—NSAIDs, hormonal suppression, and laparoscopic excision surgery—help many people but fail or cause intolerable side effects in others [1][2]. That gap is why a growing number of patients have explored cannabis. Online surveys from Australia, Canada, the US, and the UK consistently find that 10–25% of endometriosis patients have tried cannabis for symptom relief, and most who try it report at least some benefit, especially for pain and sleep [3][4] Weak / limited.
The catch: those are self-reports, not controlled trials. There is no published randomized, placebo-controlled trial of cannabis or any single cannabinoid in endometriosis. So we're working with patient experience and biological plausibility, not proof of efficacy.
This is not medical advice. If you have endometriosis or suspect you do, work with a clinician—ideally one with endometriosis expertise—before using cannabis as part of your symptom management.
What probably works
Honestly, nothing about cannabis in endometriosis meets a strict "probably works" bar. There are no randomized controlled trials. The strongest claim the evidence supports is:
Subjective short-term pain and sleep relief in some patients. Across multiple independent surveys, the most consistently reported benefits are reduction in pelvic pain severity and improved sleep, with effect sizes patients describe as meaningful [3][4][5] Weak / limited. This is consistent with the broader chronic-pain literature, where cannabis shows small-to-modest analgesic effects in other pain conditions [6] Weak / limited.
That is the entire "probably" column. Anyone claiming certainty beyond patient-reported symptom relief is overselling.
What might work
Reducing use of other medications. In Armour et al.'s Australian survey, a majority of cannabis-using endometriosis patients reported cutting back on opioids, benzodiazepines, or other analgesics [3] Weak / limited. This is self-report only; no objective verification or follow-up on whether symptom control was maintained.
Helping with associated symptoms. Nausea, anxiety, gut cramping, and dyspareunia (painful sex) were rated as improved by substantial minorities in survey work [3][4] Weak / limited. These are secondary outcomes, not the primary reason most patients try cannabis.
CBD-dominant preparations for pain and inflammation. Biologically plausible: the endocannabinoid system is expressed in endometrial tissue, and CB1/CB2 signaling modulates pain and inflammation in animal models [7][8] Strong evidence. Animal models of endometriosis show cannabinoid agonists reduce lesion growth and pain hypersensitivity [9] Weak / limited. Whether that translates to humans is unknown and untested.
Vaginal or rectal suppositories for localized pelvic pain. Popular in patient communities but there is essentially no controlled data on absorption, distribution, or efficacy Anecdote.
What doesn't work or has weak evidence
Cannabis as a cure or disease-modifying therapy. There is no human evidence that cannabis shrinks endometriotic lesions or alters disease progression No data. Animal data is preliminary and has not led to clinical trials [9].
"Indica for cramps, sativa for energy" guidance. The indica/sativa classification does not reliably predict chemical profile or effects. Strain-name reliability is a common misconception—see that article for details Disputed.
Specific terpene claims (e.g. "beta-caryophyllene at X% relieves pelvic pain"). Mechanistically interesting in cell culture, clinically unproven in endometriosis No data.
High-THC flower as a long-term pain strategy. Daily high-THC use carries tolerance, dependence, and cannabinoid hyperalgesia (paradoxical pain worsening) that can worsen pain conditions over months to years [11] Weak / limited.
What we don't know
A lot remains unknown:
- Optimal cannabinoid, dose, and route. No studies compare THC vs. CBD vs. ratios, nor do any compare routes (flower, oil, suppository, etc.) in endometriosis.
- Cannabis and fertility. Whether cannabis affects conception, ovulation, or embryo implantation in people with endometriosis who want to conceive. General reproductive data suggests THC may impair ovulation and embryo implantation in animal models; human data is limited and concerning [12] Weak / limited.
- Interactions with standard hormonal therapy. No clinical interaction studies exist between cannabis and GnRH analogs, progestins, or combined hormonal contraceptives.
- Long-term outcomes. Pain trajectory, surgery rates, opioid use, and disease progression in cannabis users vs. non-users over years. No cohort studies.
- Translation of animal findings. Whether any of the encouraging animal lesion-suppression findings replicate in humans.
Comparison with standard treatments
Standard treatments have actual trial evidence behind them; cannabis does not. That doesn't make cannabis useless—it makes it adjunctive at best, not a substitute.
NSAIDs (ibuprofen, naproxen): first-line for menstrual pain. Modest evidence for endometriosis-specific pain; widely used [1] Strong evidence.
Combined hormonal contraceptives and progestins: suppress cyclic pain in many patients; well-studied with randomized trials [1] Strong evidence.
GnRH agonists/antagonists (e.g., elagolix): effective for moderate-to-severe pain; significant side effects including bone loss [2] Strong evidence.
Laparoscopic excision surgery: the only intervention shown in randomized trials to remove disease and improve pain, though recurrence is common over time [1] Strong evidence.
Pelvic floor physical therapy: underused; evidence growing for the muscular and neuropathic component of endometriosis pain Weak / limited.
Cannabis: zero randomized controlled trials in endometriosis; positive patient-reported outcomes in surveys Weak / limited.
A reasonable framing: cannabis has weaker clinical evidence than all standard treatments. It is not in the same tier as surgery, hormones, or NSAIDs for proven efficacy in endometriosis.
Risks and practical considerations
Dependence and tolerance. Approximately 1 in 10 adult cannabis users develop cannabis use disorder; risk is substantially higher with daily high-THC use [11] Strong evidence. Tolerance can require escalating doses over weeks to months, increasing side effects.
Cannabinoid hyperemesis syndrome. Heavy chronic users—particularly those using high-THC daily—can develop cyclic vomiting that mimics or worsens endometriosis-related gastrointestinal symptoms [13] Strong evidence. This can create diagnostic confusion and delay appropriate care.
Pregnancy and fertility. Cannabis is not recommended during pregnancy or while trying to conceive. THC crosses the placenta and is associated with low birth weight, altered brain development, and developmental concerns in exposed offspring [12][14] Strong evidence.
Drug interactions. CBD inhibits hepatic CYP3A4 and CYP2C19 enzymes and can raise blood levels of some medications Strong evidence. Relevant if you take SSRIs, anticoagulants, anti-epileptics, or other CYP-metabolized drugs. Check with a pharmacist.
Diagnostic delay. The most dangerous risk: using cannabis to manage worsening pelvic pain instead of seeking medical evaluation. Endometriosis already has an average diagnostic delay of 7–10 years, and self-managing pain can defer imaging, surgery, or other necessary investigation [1]. Don't add to it.
Cost and legality vary enormously by jurisdiction. In many places, cannabis remains illegal or tightly restricted, creating access, affordability, and legal concerns.
Again: this article is not medical advice. It's a summary of what the evidence does and doesn't show. Decisions about your body and treatment belong between you and a clinician you trust.
Sources
- Peer-reviewed Zondervan KT, Becker CM, Missmer SA. Endometriosis. New England Journal of Medicine. 2020;382(13):1244–1256.
- Peer-reviewed Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852.
- Peer-reviewed Armour M, Sinclair J, Noller G, et al. Illicit cannabis usage as a management strategy in New Zealand women with endometriosis: an online survey. Journal of Women's Health. 2021;30(10):1485–1492.
- Peer-reviewed Sinclair J, Collett L, Abbott J, Pate DW, Sarris J, Armour M. Cannabis use, a self-management strategy among Australian women with endometriosis: results from a national online survey. Journal of Obstetrics and Gynaecology Canada. 2020;42(3):256–261.
- Peer-reviewed Reinert AE, Hibner M. Self-reported efficacy of cannabis for endometriosis pain. Journal of Minimally Invasive Gynecology. 2019;26(7):S72.
- Peer-reviewed Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews. 2018;3:CD012182.
- Peer-reviewed Sanchez AM, Vigano P, Mugione A, Panina-Bordignon P, Candiani M. The molecular connections between the cannabinoid system and endometriosis. Molecular Human Reproduction. 2012;18(12):563–571.
- Peer-reviewed Bouaziz J, Bar On A, Seidman DS, Soriano D. The clinical significance of endocannabinoids in endometriosis pain management. Cannabis and Cannabinoid Research. 2017;2(1):72–80.
- Peer-reviewed Escudero-Lara A, Argerich J, Cabañero D, Maldonado R. Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain. eLife. 2020;9:e50356.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
- Peer-reviewed Brents LK. Marijuana, the endocannabinoid system and the female reproductive system. Yale Journal of Biology and Medicine. 2016;89(2):175–191.
- Peer-reviewed Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment—a systematic review. Journal of Medical Toxicology. 2017;13(1):71–87.
- Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics & Gynecology. 2017;130(4):e205–e209.
- Peer-reviewed Brown JD, Winterstein AG. Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine. 2019;8(7):989.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Chronic Pain — Evidence summary of cannabis for chronic pain: modest benefit for some, real risks, and ho...
- Cannabis and Neuropathic Pain — Modest efficacy for some neuropathic pain types; best evidence is short-term and third-lin...
- Cannabis and Pelvic Pain — Survey data shows relief; controlled trials are sparse. Here's what the evidence actually...
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis and Sickle Cell Pain — Limited evidence suggests cannabis may reduce pain interference in sickle cell disease, bu...